USANA HEALTH SCIENCES INC
Financial highlights
| Metric | FY 01/03/26 | FY 12/28/24 | FY 12/30/23 | FY 12/31/22 | FY 01/01/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.9 | $0.9 | $0.9 | $1.0 | $1.2 |
| Operating income | $<0.1 | $0.1 | $0.1 | $0.1 | $0.2 |
| Net income | $<0.1 | $<0.1 | $0.1 | $0.1 | $0.1 |
| Cash Flow Statement | |||||
| Free cash flow | $<0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
| Share repurchases | $<0.1 | $<0.1 | $<0.1 | $<0.1 | $0.2 |
Shares outstanding 18.5M · Free float 50.6%
Annual filing data through FY ended January 3, 2026; float as of September 22, 2026.